<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110-pharmaceuticals-12-00157">
 <label>110.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Eyer</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Nencka</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Huvarova</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Palus</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Joao Alves</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gould</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>De Clercq</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Růžek</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Nucleoside Inhibitors of Zika Virus</article-title>
  <source>J. Infect. Dis.</source>
  <year>2016</year>
  <volume>214</volume>
  <fpage>707</fpage>
  <lpage>711</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jiw226</pub-id>
  <?supplied-pmid 27234417?>
  <pub-id pub-id-type="pmid">27234417</pub-id>
 </element-citation>
</ref>
